What is CITRINE GLOBAL CORP's earnings per share (EPS)?

CITRINE GLOBAL CORP (CTGL) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CITRINE GLOBAL CORP (CTGL) Financials

CTGL

FY2025 annual

Net Income -$1.9M +16.6% YoY

EPS (Diluted) $0.00 YoY not available

Free Cash Flow -$582K YoY not available

Operating Cash Flow -$468K -11600.0% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 20, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CTGL SEC filings page.

This page shows CITRINE GLOBAL CORP (CTGL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CTGL FY2025 2026-08-29

Liabilities have expanded while assets remain small, producing negative equity and acute short-term balance-sheet pressure.

Total liabilities more than doubled from $2.5M in FY2021 to $5.5M in FY2025. With FY2025 assets at $1.2M, negative equity of -$4.3M reflects obligations exceeding the recorded asset base rather than ordinary operating leverage.

The current ratio fell from 0.3x in FY2021 to about 0.0x in FY2025, showing that near-term liabilities became increasingly disconnected from current assets. The reported liquidity comparison was just 0.3 months of FY2025 operating outflow, reinforcing that the balance-sheet pressure is immediate rather than only long-term.

FY2025 net loss was -$1.9M while operating cash flow was -$468K, so the two measures differ in magnitude but agree that operations did not generate cash. Financing cash flow of $591K supplied the year's offset, making funding activity—not operations—the source of net cash support.

Financial Health Signals

Financial health score not available

CITRINE GLOBAL CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/6

CITRINE GLOBAL CORP passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing

N/A

CITRINE GLOBAL CORP reported a net loss of $1.9M while operations used $468K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income

-$260K

YoY+2.6%

CITRINE GLOBAL CORP reported -$260K in net income in Q1 2026. This represents an increase of 2.6% from the same quarter a year earlier.

EPS (Diluted)

$0.00

CITRINE GLOBAL CORP earned $0.00 per diluted share (EPS) in Q1 2026.

Revenue

Not reported for Q1 2026.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$3K

YoY-95.5%

QoQ-70.0%

CITRINE GLOBAL CORP held $3K in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding

1.25B

YoY+19.5%

QoQ0.0%

5Y CAGR+5.8%

CITRINE GLOBAL CORP had 1.25B shares outstanding in Q1 2026. This represents an increase of 19.5% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

None of these metrics is reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

CTGL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTGL quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$12K-92.0%	$149K-40.7%	$251K	N/A	$0	$0-100.0%	$6K+0.4%	$6K-0.3%	$6K-93.7%	$93K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$14K-91.2%	$159K-27.5%	$219K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	-$2K+98.9%	-$186K-666.3%	$33K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	$120K+25.0%	$96K+464.7%	$17K-85.2%	$115K-60.3%	$289K+2.3%	$282K-71.9%	$1.0M+151.7%	$399K+92.5%	-$207K+882.8%	$21K-27.3%	$29K-42.0%	$50K
SG&A Expenses	N/A	N/A	N/A	N/A	$1.9M-42.4%	$3.2M-61.2%	$8.3M	N/A	$2.0M-18.6%	$2.5M+199.3%	$823K+152.9%	$325K+107.9%	-$4.1M-379.1%	$1.5M+436.5%	$276K+164.1%	$105K
Operating Income	N/A	-$1.3M-1.4%	-$1.2M+46.1%	-$2.3M-15.7%	-$2.0M+40.4%	-$3.3M+59.9%	-$8.3M	N/A	$2.1M-26.1%	$2.9M+57.5%	$1.8M+352.3%	-$724K+83.3%	-$4.3M-188.7%	-$1.5M-400.1%	-$300K-384.8%	-$62K
EBITDA	N/A	N/A	N/A	-$2.3M-15.7%	-$2.0M+40.5%	-$3.3M+59.9%	-$8.3M	N/A	$2.2M-25.8%	$2.9M+57.3%	$1.8M	N/A	-$4.3M-188.6%	-$1.5M-400.5%	-$299K-385.5%	-$62K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$8K+94.8%	-$154K-302.2%	$76K+1461.1%	$5K	N/A
Net Income	N/A	-$1.9M+16.6%	-$2.3M+26.0%	-$3.1M-17.4%	-$2.6M+41.4%	-$4.5M+47.7%	-$8.6M	N/A	$2.2M+175.5%	-$2.9M-254.2%	$1.9M+341.7%	-$767K+82.4%	-$4.4M-202.0%	-$1.4M-314.0%	-$349K-394.5%	-$71K
EPS (Basic)	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	N/A	-$0.06+14.3%	-$0.07+41.7%	-$0.12-6.2%	-$0.11-82.3%	-$0.06	N/A	N/A	N/A	N/A
EPS (Diluted)	—	$0.00	$0.00	$0.00	$0.00	N/A	N/A	-$0.06+14.3%	-$0.07+46.2%	-$0.13-15.0%	-$0.11	-$0.06	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	37M+14.9%	33M+36.8%	24M+45.3%	16M	12M	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
R&D Expenses	N/A	N/A	N/A	$31K	$32K	N/A	N/A	N/A
Operating Income	-$281K-18.1%	N/A	-$377K-43.3%	-$217K+17.8%	-$238K+40.9%	N/A	-$263K+49.8%	-$264K+53.1%
Net Income	-$260K+2.6%	N/A	-$386K-1.6%	-$675K+46.0%	-$267K-6.0%	N/A	-$380K-214.0%	-$1.3M-84.9%
EPS (Basic)	$0.00	N/A	N/A	N/A	$0.00	N/A	N/A	N/A
EPS (Diluted)	$0.00	N/A	N/A	N/A	$0.00	N/A	N/A	N/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, SG&A Expenses, EBITDA, Interest Expense, Income Tax, Diluted Shares (Avg).

CTGL Balance Sheet

CTGL quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$1.2M-25.2%	$1.6M-34.8%	$2.5M+89.9%	$1.3M+24.1%	$1.1M-66.0%	$3.1M+1109.0%	$257K-77.8%	$1.2M+34.3%	$862K+110.0%	$411K+0.6%	$408K-77.2%	$1.8M+172.5%	$656K+227.9%	$200K+72.8%	$116K
Current Assets	$166K+18.6%	$140K-45.7%	$258K+39.5%	$185K-47.0%	$349K-86.8%	$2.6M+3131.6%	$82K-91.4%	$958K+29.4%	$740K+148.4%	$298K-11.5%	$337K-81.2%	$1.8M+172.6%	$656K+228.6%	$200K+73.6%	$115K
Cash & Equivalents	$10K+900.0%	$1K-85.7%	$7K-90.9%	$77K-71.5%	$270K+31.1%	$206K+1068.1%	$18K-96.3%	$475K-19.5%	$590K+114.4%	$275K+8.1%	$254K-75.6%	$1.0M+58.8%	$656K+2966.9%	$21K-80.7%	$111K
Short-Term Investments	$0	$0	$0	$0-100.0%	$15K	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	$35K-86.1%	$249K+500.6%	$41K	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	$9K-32.1%	$13K+305.7%	$3K	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$5.5M+26.7%	$4.3M-13.0%	$5.0M+31.2%	$3.8M+51.5%	$2.5M+46.6%	$1.7M+155.2%	$667K+60.0%	$417K+18.7%	$351K+18.3%	$297K-14.6%	$347K-11.5%	$392K+132.6%	$169K+22.7%	$138K+64.3%	$84K
Current Liabilities	$4.8M+32.0%	$3.6M+32.5%	$2.7M+50.6%	$1.8M+69.6%	$1.1M-37.5%	$1.7M+373.3%	$360K-6.5%	$385K+17.5%	$328K+15.4%	$284K-18.2%	$347K-10.9%	$390K+143.4%	$160K+30.1%	$123K+94.0%	$63K
Non-Current Liabilities	$711K0.0%	$711K-68.3%	$2.2M+13.5%	$2.0M+38.0%	$1.4M	$0-100.0%	$8K-75.1%	$32K+36.5%	$23K+85.0%	$13K	$0-100.0%	$3K-67.1%	$9K-40.1%	$14K-28.7%	$20K
Total Equity	-$4.3M-58.0%	-$2.7M-8.9%	-$2.5M-0.2%	-$2.5M-71.6%	-$1.4M-202.6%	$1.4M+442.2%	-$410K-155.3%	$741K+45.0%	$511K+348.8%	$114K+86.5%	$61K-95.6%	$1.4M+186.4%	$488K+678.7%	$63K+95.2%	$32K
Retained Earnings	-$33.7M-6.0%	-$31.8M-7.8%	-$29.5M-11.8%	-$26.4M-11.1%	-$23.8M-23.5%	-$19.2M-81.5%	-$10.6M-21.5%	-$8.7M-32.8%	-$6.6M-77.0%	-$3.7M-99.7%	-$1.9M+70.3%	-$6.3M	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$1.2M-27.8%	$1.2M-25.2%	$1.3M-15.5%	$1.2M-24.7%	$1.7M-34.1%	$1.6M-34.8%	$1.6M-11.1%	$1.6M+7.6%
Current Assets	$164K-19.2%	$166K+18.6%	$161K+40.0%	$141K+10.2%	$203K+45.0%	$140K-45.7%	$115K-71.3%	$128K-71.4%
Cash & Equivalents	$3K-95.5%	$10K+900.0%	$7K	$8K+166.7%	$67K+1575.0%	$1K-85.7%	N/A	$3K-90.0%
Short-Term Investments	$0	$0	$0	$0	$0	$0	N/A	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	N/A	$0
Total Liabilities	$5.7M+28.8%	$5.5M+26.7%	$5.2M-7.8%	$4.7M-11.8%	$4.5M-13.9%	$4.3M-13.0%	$5.7M+26.5%	$5.4M+26.0%
Current Liabilities	$5.0M+34.3%	$4.8M+32.0%	$4.5M+36.6%	$4.0M+29.4%	$3.7M+28.0%	$3.6M+32.5%	$3.3M+37.1%	$3.1M+47.0%
Non-Current Liabilities	$711K0.0%	$711K0.0%	$711K-69.9%	$711K-68.5%	$711K-68.4%	$711K-68.3%	$2.4M+14.1%	$2.3M+5.4%
Total Equity	-$4.5M-63.0%	-$4.3M-58.0%	-$3.9M+4.8%	-$3.5M+6.3%	-$2.8M-5.7%	-$2.7M-8.9%	-$4.1M-51.5%	-$3.8M-35.9%
Retained Earnings	-$34.0M-6.0%	-$33.7M-6.0%	-$33.1M-5.6%	-$32.7M-5.6%	-$32.1M-7.8%	-$31.8M-7.8%	-$31.4M-11.9%	-$31.0M-11.0%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

CTGL Cash Flow Statement

CTGL quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$571K	-$468K-11600.0%	-$4K+98.0%	-$199K+64.9%	-$567K+2.6%	-$582K+16.4%	-$696K+43.2%	-$1.2M+48.6%	-$2.4M-62.3%	-$1.5M-14.0%	-$1.3M-218.4%	-$405K+77.6%	-$1.8M-411.8%	-$353K-100.8%	-$176K-6106.7%	$3K
Depreciation & Amortization	N/A	N/A	N/A	$2K0.0%	$2K0.0%	$2K-71.4%	$7K-77.2%	$31K+26.1%	$24K+15.0%	$21K+34.5%	$16K	N/A	$2K+621.8%	$321+2.9%	$312+113.7%	$146
Stock-Based Compensation	N/A	$51K-81.9%	$281K-73.9%	$1.1M+37.0%	$787K+72.6%	$456K	N/A	$12K-4.1%	$13K-99.0%	$1.3M+184.9%	$442K	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	$114K	N/A	N/A	$4K-98.4%	$252K+4100.0%	$6K-45.3%	$11K-88.8%	$98K+1751.4%	$5K-88.2%	$45K	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	-$582K	N/A	N/A	-$571K+31.5%	-$834K-18.8%	-$702K+43.2%	-$1.2M+50.2%	-$2.5M-68.4%	-$1.5M-10.5%	-$1.3M	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	-$114K	N/A	N/A	$11K-96.2%	$286K+146.5%	-$615K-2382.7%	$27K+123.9%	-$113K-512.6%	-$18K+67.5%	-$57K-173.1%	$77K+434.9%	-$23K-136.3%	$64K	N/A	-$947
Financing Cash Flow	$621K	$591K+29650.0%	-$2K-101.5%	$130K-63.9%	$360K+2.9%	$350K-76.7%	$1.5M+98.2%	$757K-68.1%	$2.4M+33.4%	$1.8M+35.6%	$1.3M+155.8%	$513K-77.5%	$2.3M+146.7%	$924K+971.2%	$86K+115.8%	$40K

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$160K-180.7%	-$246K-1046.2%	-$106K	-$59K-493.3%	-$57K-26.7%	$26K+151.0%	$0+100.0%	$15K+146.9%
Stock-Based Compensation	N/A	N/A	N/A	N/A	$31K-65.9%	N/A	N/A	N/A
Investing Cash Flow	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$153K+24.4%	$249K+1096.0%	$219K+7400.0%	$0+100.0%	$123K+192.9%	-$25K	-$3K-103.8%	-$16K

Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

CTGL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTGL quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	-16.7%	-124.5%	13.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	-69308.3%	N/A	846.1%	N/A	N/A	N/A	-74267.7%	-25834.9%	-5152.0%	-66.5%
Net Margin	N/A	N/A	N/A	N/A	N/A	-71991.7%	N/A	858.0%	N/A	N/A	N/A	-74958.6%	-24922.9%	-6003.2%	-76.0%
Return on Equity	N/A	N/A	N/A	N/A	N/A	-615.8%	N/A	290.9%+849.8pp	-558.9%-2185.6pp	1626.7%+2881.8pp	-1255.1%-942.5pp	-312.7%-16.2pp	-296.5%+261.1pp	-557.6%-337.6pp	-220.0%
Return on Assets	-158.3%-16.4pp	-141.9%-16.9pp	-124.9%+77.2pp	-202.1%+226.0pp	-428.1%-149.8pp	-278.2%	N/A	186.2%+517.7pp	-331.4%-782.9pp	451.5%+639.3pp	-187.8%+56.2pp	-244.1%-23.8pp	-220.3%-45.8pp	-174.4%-113.5pp	-61.0%
Current Ratio	0.030.0x	0.04-0.1x	0.090.0x	0.10-0.2x	0.33-1.2x	1.56+1.3x	0.23-2.3x	2.49+0.2x	2.26+1.2x	1.05+0.1x	0.97-3.6x	4.59+0.5x	4.10+2.5x	1.62-0.2x	1.81
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	1.21	N/A	0.56-0.1x	0.69-1.9x	2.60-3.1x	5.68+5.4x	0.28-0.1x	0.35-1.9x	2.20-0.4x	2.61
Asset Turnover	N/A	N/A	N/A	N/A	N/A	0.00-0.6x	0.58+0.4x	0.22	N/A	0.000.0x	0.000.0x	0.000.0x	0.010.0x	0.03-0.8x	0.80
FCF Margin	N/A	N/A	N/A	N/A	N/A	-5850.0%	-829.4%	-988.2%	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Return on Assets	-21.4%-5.5pp	N/A	-28.7%-4.8pp	-56.0%+22.1pp	-15.9%-6.0pp	N/A	-23.9%-17.1pp	-78.1%-32.7pp
Current Ratio	0.030.0x	0.030.0x	0.040.0x	0.040.0x	0.050.0x	0.04-0.1x	0.03-0.1x	0.04-0.2x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$4.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
CITRINE GLOBAL CORP CTGL	FY2025	N/A	-$1.9M	N/A	$6.7M	—
UMEWORLD LIMITED UMEWF	FY2025	$2K	-$258K	N/A	$47.1M	—
NEXT MEATS HLDGS INC NXMH	FY2023	$1.4M	-$4.8M	N/A	$38.8M	—
LIMITLESS X HOLDINGS INC LIMX	FY2025	$947K	N/A	N/A	$4.6M	—
STARCO BRANDS INC CL A STCB	FY2025	N/A	-$20.9M	N/A	$25.3M	—

Where CITRINE GLOBAL CORP Ranks

Frequently Asked Questions

Is CITRINE GLOBAL CORP profitable?

No, CITRINE GLOBAL CORP (CTGL) reported a net income of -$1.9M in fiscal year 2025.

What is CITRINE GLOBAL CORP's free cash flow?

CITRINE GLOBAL CORP (CTGL) recorded an outflow of $582K in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CITRINE GLOBAL CORP's operating cash flow?

CITRINE GLOBAL CORP (CTGL) recorded an outflow of $468K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are CITRINE GLOBAL CORP's total assets?

CITRINE GLOBAL CORP (CTGL) had $1.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What are CITRINE GLOBAL CORP's capital expenditures?

CITRINE GLOBAL CORP (CTGL) invested $114K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does CITRINE GLOBAL CORP have outstanding?

CITRINE GLOBAL CORP (CTGL) had 1.25B shares outstanding as of fiscal year 2025.

What is CITRINE GLOBAL CORP's current ratio?

CITRINE GLOBAL CORP (CTGL) had a current ratio of 0.03 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is CITRINE GLOBAL CORP's return on assets (ROA)?

CITRINE GLOBAL CORP (CTGL) had a return on assets of -158.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does CITRINE GLOBAL CORP's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, CITRINE GLOBAL CORP (CTGL) held $10K in cash, cash equivalents and investments, and reported an operating cash outflow of $468K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is CITRINE GLOBAL CORP's debt-to-equity ratio negative or not reported?

CITRINE GLOBAL CORP (CTGL) has negative shareholder equity of -$4.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is CITRINE GLOBAL CORP's Piotroski F-Score?

CITRINE GLOBAL CORP (CTGL) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CITRINE GLOBAL CORP's earnings high quality?

CITRINE GLOBAL CORP (CTGL) reported a net loss of $1.9M while operations used $468K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.